Pathologic down-staging and complete pathologic response with gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder

被引：0
|
作者：
Psutka, Sarah P.
Olumi, Aria F.
Feldman, Adam S.
Saylor, Philip James
Kaufman, Donald S.
Lee, Richard J.
机构：
[1] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.307
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
307
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lack of Pathologic Down-Staging With Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder
    Weight, Christopher J.
    Garcia, Jorge A.
    Hansel, Donna E.
    Fergany, Amr F.
    Campbell, Steven C.
    Gong, Michael C.
    Jones, J. Stephen
    Klein, Eric A.
    Dreicer, Robert
    Stephenson, Andrew J.
    [J]. CANCER, 2009, 115 (04) : 792 - 799
  • [2] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    [J]. CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
  • [3] Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Choi, Se Jin
    Park, Kye Jin
    Lee, Goeun
    Kim, Mi-hyun
    Kim, Jeong Kon
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2020, 126
  • [4] Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma
    Pokuri, Venkata K.
    Syed, Johar R.
    Yang, Zhengyu
    Field, Erinn P.
    Cyriac, Susanna
    Pili, Roberto
    Levine, Ellis Glenn
    Azabdaftari, Gissou
    Trump, Donald L.
    Guru, Khurshid
    George, Saby
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E59 - E65
  • [5] Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, doxorubicin hydrochloride, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle-invasive urothelial cell carcinoma of the bladder
    Wright, Jonathan Lawrence
    Lee, Franklin
    Harris, William Proctor
    Cheng, Heather H.
    Zhao, Song
    Champion, Thomas
    Gore, John L.
    Dean, James
    Porter, Michael P.
    Yu, Evan Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
    Lee, Franklin C.
    Harris, William
    Cheng, Heather H.
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael
    Yu, Evan Y.
    Wright, Jonathan L.
    [J]. ADVANCES IN UROLOGY, 2013, 2013
  • [7] Neoadjuvant gemcitabine-cisplatin (GC) for muscle-invasive bladder cancer (MIBC): Does midway CT staging predict for pathologic complete response (pCR)?
    Seah, Jo-An
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Alimohamed, Nimira
    Joshua, Anthony Michael
    Knox, Jennifer J.
    Tannock, Ian
    Sridhar, Srikala S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
    Sung, Hyun Hwan
    Kim, Hana
    Kim, Ryul
    Kim, Chan Kyo
    Kwon, Ghee Young
    Park, Won
    Song, Wan
    Jeong, Byong Chang
    Park, Se Hoon
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 168 - 174
  • [9] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    [J]. PLOS ONE, 2016, 11 (05):
  • [10] GEMCITABINE AND CISPLATIN NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA: PREDICTING RESPONSE AND ASSESSING OUTCOMES.
    Gandhi, Nilay
    Baras, Alexander
    Munari, Enrico
    Faraj, Sheila
    Reis, Leonardo
    Liu, Jen-Jane
    Kates, Max
    Hoque, Mohammad
    Berman, David
    Hahn, Noah
    Eisenberger, Mario
    Netto, George
    Schoenberg, Mark
    Bivalacqua, Trinity
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E923 - E924
12345